| 3.70 Data as of May 22 |  +0.16 / +4.52%Today’s Change | 1.55 Today|||52-Week Range 4.20 | +49.19% Year-to-Date |
| Previous close | 3.54 |
| Today’s open | 3.58 |
| Day’s range | -- - -- |
| Volume | 102,711 |
| Average volume (3 months) | 215,298 |
| Market cap | $180.2M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | +37.68% |
| P/E ratio | NM |
| Price/Sales | 1.87 |
| Price/Book | 18.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| FCSCFibrocell Science In... | +0.12 | +2.54% |
| MGMistras Group Inc | -0.08 | -0.38% |
| CLDXCelldex Therapeutics... | -0.08 | -0.63% |
| CVDCovance Inc | -0.64 | -0.84% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $0.01 |
| Annual revenue (last year) | $59.9M |
| Annual profit (last year) | $65.0K |
| Net profit margin | 0.11% |
Sector Health Services |
Industry Medical/Nursing Services |
Chairman & Chief Executive Officer Douglas M. VanOort, CPA |
Chief Financial Officer George A. Cardoza, MBA |
Corporate headquarters Fort Myers, Florida |
.
